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This study explored how social workers in private practice view the role of psychotropic 
medications in treatment and handle psychopharmacological issues in practice. It specifically 
focused on social workers’ perspectives on the helpfulness of psychotropic medications and the 
nature of their communication with prescribing providers. Split treatment has become the 
standard arrangement for providing both psychotherapy and psychopharmacotherapy to mental 
health clients, yet there is limited research on issues that social workers encounter in split 
treatment relationships and how they view them. Fifty-six independently licensed social workers 
who provided psychotherapy in private practice completed a mixed method survey that asked 
them to share demographic information about their practices, their perspectives on the 
helpfulness of psychotropic medications and prescribing providers for their clients, and the 
nature and frequency of their communication with prescribing providers. The findings indicate 
that overall, social workers in private practice find psychotropic medications and prescribing 
providers to be helpful for their clients, but there is a fair amount of variation depending on the 
type of mental illness being treated and the type of prescribing provider in the split treatment 
relationship. The findings also indicate that communication between social workers and 
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The purpose of this study is to explore the relationships that private practice social 
workers have with psychotropic medications when practicing psychotherapy, specifically 
looking at their own perspectives on psychotropic medications in practice and the nature of their 
professional relationships with prescribers of psychotropic medications. This study was 
conducted with the goal of filling the Smith College School for Social Work masters thesis 
requirement for the masters in social work (MSW) degree program.  It is based on a mixed 
method survey tool that was disseminated to participants via the internet or a mailed paper copy. 
In order to have taken part in the study, participants were required to be independently licensed 
clinical social workers who were providing psychotherapy in private practice to adult clients.  
Much of my desire to research this topic came from my work as a first year social work 
intern where I was placed on an inpatient psychiatric unit at a teaching hospital in New England 
for seven months. There, it was often my responsibility to coordinate care between outpatient 
therapists and prescribing providers for patients who were discharging from the unit. Many 
patients did not have outpatient providers who could prescribe psychiatric medication, and it was 
often very difficult to find prescribers who focused on mental health care, such as psychiatrists 
and psychiatric nurse practitioners. Patients often had to be discharged with the agreement that 
their primary care practitioners would monitor their responses to their psychotropic medication 
regimens. Some primary care providers were comfortable with this, but others were often very 
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hesitant, especially if the patients were being discharged on medications that were more 
complicated to manage. I was also responsible for making sure that patients had follow up 
psychotherapy services with licensed providers who were often social workers. These providers 
were also often worried about their clients not having adequate help with psychotropic 
medications. It seemed very rare that we could discharge psychiatric inpatients into the care of 
psychotherapists and psychotropic medication providers who had consistent professional 
relationships with each other. There were a few occasions where some of my patients had 
outpatient psychiatrists and outpatient therapists who did not agree on how best to treat their 
clients. They had been providing treatment with no discussion or real awareness of each other’s 
reasoning and motives, seeming as if they were almost treating different clients. The treatment 
arrangement appeared as though it could easily become iatrogenic. Some examples of what I saw 
included a therapist who neglected to bring the psychiatric nurse practitioner into the loop in 
order to discuss the role of medications in a client’s recent suicidal crisis; or, a psychiatrist who 
was not willing to consider feedback from the clinical social worker which contradicted her 
diagnosis of bipolar affective disorder and subsequent decision to place the client on lithium. 
 In thinking about the possiblity of becoming a clinical social worker and 
psychotherapist, I wanted to find out more about how licensed clinical social workers in the 
world of outpatient psychotherapy were percieving and handling dilemmas related to 
psychotropic medications, since it seemed like the system of provding split-treatment for mental-
helath clients had many weaknesses. After looking into some of the current research that was 
available, it became apparent to me that there were not many updated studies that looked into 
into the state of the split-treatment system and relationship to clinical social workers. The goal of 
the following chapter is to provide a review of the literature relevant to the roles of social 
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workers as psychotherapists when psychotropic medication is part of the treatment process. It 
also provides a theoretical and empirical foundation for this study. Following the literature 
review chapter is the methodology on how the study was conducted. It is presented in a way so 
that this study can be easily replicated or built upon in the future. Finally, the discusion chapter 
reviews much of the findings, and highlights their implication for social work and mental helath 
practice. It also points out other topics for future study which I uncovered through my work but 








Split Treatment and Professional Responsibilities:  
Today, "split treatment"is one of the most predominant forms of service provided to 
individuals who suffer from mental illness. It is a major reason why social workers in private 
practice and prescribing provider relationships are important in the effective treatment of mental 
illnesses. In split treatment, patients generally have two practitioners who are accountable for 
their mental health needs. First is the psychotherapist, who is often a non-physician, which 
includes social workers and psychologists. The second individual is a "pharmacotherapist" or 
prescriber of psychotropic medication (Kahn, 1991).   
Balon states that split treatment has both positive and negative aspects. The positive 
aspects include cost-effectiveness, more time spent with clients by providers, a broader range of 
talent available to clients, a greater chance for clients to have at least one provider with a similar 
ethnic background, and more opportunities for providers to offer professional support to each 
other. Negative aspects include the possibility for "splitting" to occur between clients and 
providers, greater potential for discrepancies in communication between individuals, intervention 
decisions made by one provider without considering information from the other provider, 
confidentiality, legal and clinical responsibility grey areas, and the fact that collaboration time is 
often not reimbursable (Balon, 2001). 
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Kahn (1991) states that split treatment must be a "three-way therapeutic alliance in which 
all share a common "reality" overview of the illness and the treatment plan." Kahn writes some 
of the most problematic issues in split treatment arise when providers disagree on whether or not 
to prescribe medication, along with transference and countertransference triangles between the 
providers and patient. This implies that frequent and effective communication between all 
providers and the client is necessary for split treatment to be effective  
 Gutheil and Simon go farther in the discussion of problems that can arise during 
split treatment by recommending that providers use the "Eight Cs" of collaborative treatment in 
order to safeguard clients from abandonment and other problems that can arise in split treatment 
relationships. These are "Clarity, Contract, Communication, Consent, Contact, Comprehensive 
view, Credentialing, and Consultation".  In summary, the "Eight Cs" state that providers should 
have a clear understanding of each other's responsibilities, and should focus on maintaining 
regular and cooperative communication with each other. This process can be aided by having 
written agreements outlining each other's responsibilities and reaching out to other providers for 
consultation when necessary (2003). 
Bentley, Walsh, and Farmer (2005) write that for social workers, the practice of referring 
clients for medication should be taken “as seriously as they do other aspects of service delivery.” 
They advise that the social worker’s responsibilities in the referral process should include 
establishment and maintenance of collaboration between the social worker and prescribing 
provider, providing psychoeducation on medications for clients and other supportive individuals 
involved in their treatment, exploring the meaning of psychotropic medication with clients and 
their supporters, helping clients to prepare for meetings with prescribing providers and then 
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following up on the outcome of these meetings, and management of legal and ethical issues 
related to treatment with medications.  
 The next two sections in this literature review discuss theories and paradigms that 
could influence social workers’ perspectives and interventions related to practice with 
psychotropic medications, specifically if and when they choose to refer clients for medication 
consultation. One point that is argued to be universal no matter what theoretical foundation is 
used is that the possible consequences of making the choice to not refer a client who might need 
medication are far worse than referring one who ultimately does not need medication (King & 
Anderson, 2004; Klerman, 1990; Malcom, 1986). Social workers do not have the proper training 
to make the decision to prescribe a medication, but they do have responsibility of making sure 
that clients have access to levels of mental health treatment beyond scope of social work 
practice. All clinicians must keep this in mind when faced with the decision to refer a client for 
psychotropic medications. However, this is a topic beyond the scope of this review. 
 
Biopsychosocial and Medical Models:  
Concepts pertinent to the study of the social worker's relationship with 
psychopharmacology include the medical model of treating mental illness. This is the driving 
force behind psychopharmacology, since it assumes that mental illness can be fixed though 
biological changes. The biopsychosocial model, or BPS model, of mental illness is what frames 
most clinical social worker training. A 2010 study on peoples’ perceptions of psychiatrists found 
that social workers value providers who can look beyond the medical model in terms of 
understanding mental illness (Bhugra, Gupta, Smyth, and Webber, 2010). Although not every 
psychiatric or social work paper explicitly states and debates theory on the medical vs. the BPS 
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models, they are both very important for the social worker to consider at the level of practice 
because each one informs different ways of forming assessments and treating clients.  In 
empirical literature relating to the question of "How do social workers in private practice view 
the role of psychotropics in treatment and handle psychopharmacological issues in practice?” the 
significance of the medical models and BPS models are not explicitly discussed. Rather, it seems 
that there is an implied understanding that these studies are supported by variations of either 
model. It is important to explore the concepts and theories from both of these models, because 
they are the primary foundations for psychopharmacological and social work practice. In 
working to answer the research question in this study, the assumption is that social workers 
responses will be informed by their views on both of these models.  
 Social workers who focus on using evidence based practice, or EBP, use the medical 
model to inform their practice as stated here by Adams, Matto, and Lacroy (2009). “EVIDENCE-
BASED PRACTICE (EBP) is a term that is now widely used in social work and psychosocial 
disciplines. Modeled after evidence-based medicine, a state-of-the-art approach where the focus 
is on finding appropriate treatments (pharmaceutical, medical, and surgical) for a patient's 
medical conditions”. EBP focused social workers may be more willing to encourage their clients 
to consider psychotropic medications as an adjunct to therapy because of EBP's direct link to 
evidence-based medicine, or the medical model. Addams, Matto, and Lacroy acknowledge the 
usefulness of the current shift towards and EBP paradigm and social work, but they also 
advocate caution in how far this is carried out. They emphasize that using evidence based 
medicine to develop EBPs answers questions with a very narrow focus, with the goal of 
producing “wright or wrong” answers on how to treat specific diagnoses. They warn that this 
could generate too much focus on treating symptoms of specific diagnoses without looking at a 
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more holistic picture of client’s environments, strengths, concerns, previous experiences, and 
their overall need for services (2009). 
The approach that they are advocating social workers take in this excerpt is more of BPS 
approach, because they should not look at just “treating” the diagnosis, but also investigate other 
factors such as those that are part of the family environment. One of the first health care 
providers to capture the essence of this and name it the “biopsychosocial model” was the 
physician, George Engel, which he first summed up in 1977: 
To provide a basis for understanding the determinants of disease and arriving at rational 
treatments and patterns of health care, a medical model must also take into account the 
patient, the social context in which he lives, and the complementary system devised by 
society to deal with the disruptive effects of illness, that is, the physician role and the 
health care system. This requires a biopsychosocial model. (1992, p.324) 
Although antiquated, this statement clearly articulates the different levels of approach that the 
medical model does not take into account in treatment, and it still informs BPS practice in 
clinical social work and more holistic medicine today. When working on the foundations of the 
BPS model, a challenge that clinical social workers face with pharmacological issues is how 
much credit to give the biological perspective versus focusing on the psychological and social 
angles when assessing and helping clients. This includes the question of how much should 
clinical social workers try to improve upon psychological and social factors in clients’ lives 
before suggesting that they consider seeing medication prescribers. 
Treatment Techniques:  
Talk-therapy treatment techniques that clinical social workers use in private practice such 
as Psychodynamic or Cognitive Behavioral Therapy (CBT) also can inform their relationships 
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with psychopharmacology. From a historical perspective, Roose describes psychodynamic 
psychotherapy as standing in opposition to the treatment of mental illness with psychotropic 
medications, because its etiology was based on unconscious conflict, not neurobiological 
processes. This line of separation eased as the efficacy of medication in treating schizophrenia 
and some affective disorders became a reality (1998). Even though psychodynamic 
psychotherapy is commonly used alongside pharmacotherapy today, its historic foundations still 
inform the way that clinical social workers working from a psychodynamic perspective see their 
clients' problems. As a result, they may be less apt to incorporate the topic of psychotropic 
medications in dialog with their clients. Another factor is that many clinicians use a combination 
of treatment techniques based on their own preferences, the needs of their clients, and their 
clients’ preferences. In these situations, clinical social workers’ interventions may vary based on 
the situation and the theories that they incorporate from different techniques. 
 CBT is a therapeutic treatment technique that has often been viewed as a compliment to 
psychotropic treatment of mental illness, because they both have similar antidepressant and 
anxiolytic effects. The goal of CBT is to help clients recognize and change distorted thought 
patterns, which in turn has a positive affect on their emotions. Recent research is now finding 
that the combining both therapies are not necessarily advantageous as opposed to CBT or 
pharmacotherapy alone when treating specific anxiety disorders (Davis et al., 2006). Research on 
the treatment of such disorders may even suggest that in some cases it might be most effective to 
stick with only one of these treatment techniques, depending on the type of anxiety disorder a 
person is struggling with. In the case of using CBT to achieve extinction of a particular response 
to stress, the use of psychotropic medications to treat symptoms might prevent this from 
happening. On the other hand, there is new research highlighting medications that are designed 
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to enhance the effects of evidence-based psychotherapy such as CBT. These medications do not 
cover up symptoms; instead they work on neurological pathways that create the distorted 
thoughts that CBT also addresses (Davis et al., 2006). As a result of this history and new 
research, CBT social workers could have varying approaches and views on the role of 
psychotropic medications in psychotherapy, which is what the research question "How do social 
workers in private practice view the role of psychotropics in treatment and handle 
psychopharmacological issues in practice?” intends to explore, along with the approaches and 
views of social workers using other types of treatment including psychodynamic, family systems, 
eclectic, etc. 
Empirical Findings on Social Workers' Perspectives:  
Currently, empirically supported information on how social workers perceive the role of 
psychotropic medications in the treatment of people who suffer from mental health issues is 
limited. With regards to this subject, there are a few studies that are specific to working with 
younger client populations. The Moses and Kirk (2006) quantitative study that was a mail survey 
based on sampling from a random group of NASW social workers who worked with adolescents. 
This study concluded that overall, social workers feel that psychopharmacological treatment for 
adolescents is more beneficial than detrimental, although many of the respondents highlighted 
common concerns with this type of treatment. The second study by Moses (2008) on  adolescents 
investigated the topic of social workers perspectives on psychopharmacological treatment of 
adolescents with more specificity than the first, as it considered the different types of 
psychotropic medications clients were prescribed, psychological factors concerning client 
readiness, willingness, support for taking psychotropics, along with the social workers personal 
attitudes towards the use of these medications. It illustrated that the perspectives that social 
11 
 
workers have on the topic of adolescent psychopharmacology are complex, and cannot be 
summarized by the “all or nothing” categories of “helpful or harmful”. It found that social 
workers who are better informed about the effects of psychotropic medication tended to view it 
as more helpful for their clients, resulting in higher levels of client self-esteem, self efficacy, 
sense of normalcy, etc.  The study also suggested that social workers differentiate between the 
effects that medication has on target symptoms (such as behavior and mood) and the “meta 
effects” of medication, such as hopes, fears, and the meaning ascribed to taking medication. The 
study reccomended that this latter finding could be further explored by in depth-qualitative 
interviewing.This suggests that if a study's questions are too limiting, it also will not be able to 
effectively capture and summarize the themes that it is supposed to explore. 
Content and Methods of Empirical Surveys: 
 A great deal of the literature studying clinicians relationships with psychopharmacology 
is biased by gathering data from predominantly white, well educated clinicians who are members 
of NASW, such as some of the studies Moses and Walsh. An example being Walsh's 2003 study 
called “Ethical Dilemmas of Practicing Social Workers Around Psychiatric Medications”. A 
reason for this is gathering data from clinicians is much less risky from an ethical standpoint than 
gathering it from patients, and using the NASW for recruiting a sample simplifies the process. 
The problem with this is it excludes social workers who are not members of NASW, which may 
unintentionally exclude social workers with smaller financial resources since NASW's member 
fees are quite significant. It is important to consider how the NASW member pool differs from 




 In the Walsh Study, one of the major research questions regarding the topic of 
psychopharmacology was “What specific ethical dilemmas do social workers face and how 
bothersome are they?” Survey categories for ethical dilemmas were generated by feedback from 
focus groups at the beginning of the study. The pre-determined ethical dilemmas were listed on 
the mailed surveys, and respondents were asked to list how frequently they encountered each 
dilemma and numerically scale how bothersome it was. There was also an open-answer section 
for respondents to describe and rate “other” ethical dilemmas that were not addressed in the 
survey questionnaire.  
Another mixed method study investigated how competent social workers felt within their 
roles and activities concerning psychotropic medication issues by asking quantitative questions. 
A qualitative section in this study also investigated how social workers thought that they could 
be successful and what they desired to change regarding their practice with clients and other 
providers on the subject of psychotropic medications (Bentley, Walsh, & Farmer, 2005). Some 
of the topics that social workers felt most competent with include discussion of clients' feelings 
and regarding medications, monitoring compliance, encouraging clients to take medication, 
preparing clients to speak with physicians, making referrals to prescribers, communicating about 
medication compliance to prescribers, and helping families contact physicians. Social workers 
felt the least competent with assessing the severity of side effects, suggesting that physicians 
change a medication, providing clients information on how medications work, facilitating 
psychoeducation groups on medication, and ensuring that client's medication blood levels are 
checked when needed. Some of the activities in this study looked at are more likely to be 
conducted by social workers in case management roles, including helping clients fill their 
pillboxes, delivering medications, and transporting clients to physician's appointments. The use 
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of the term "physician" to signify prescribers is also confusing because many clients get their 
medication from primary care practitioners and non-physician prescribers such as nurse 
practitioners and physicians' assistants. 
All of these studies do not limit the participants to only social workers in private practice 
because most previous research appears to have mixed agency based social workers with private 
practice social workers. In private practice, they may be more isolated from other practitioners, 
specifically those who are prescribers, so they might encounter different issues or dilemmas than 
the groups of respondents that all of these studies have used. So, the goal of this study is to 
specifically target the experiences of this more isolated group. 
Empirical Findings on What Happens in Practice Involving Split-Treatment:  
There is dearth of research on what social workers are actually doing in terms of handling 
issues of psychopharmacology in their day to day work, since most of the research focuses more 
on their perspectives on how things are or how they would like them to be. Some information on 
this topic can be found in the quantitative section of Bentley, Walsh, and Farmer study 2005, 
which investigated how frequently social workers engage in activities connected to the use of 
psychotropic medications by their clients in a “typical month”. The data is presented by the 
percentage of respondents who specified that they engaged in specific activities “very 
frequently”. Over 70% of respondents said that they frequently make referrals to physicians for 
medication consultation, and discuss with clients “feelings about taking medication” and the 
“desired combined effects of medication and psychosocial interventions”, but only 46% consult 
with physicians very frequently regarding the effectiveness of client’s medications. A potential 
problem with this study is the questions regarding frequency of engaging in activities were 
subjective. Instead of asking for quantitative answers on how frequently respondents engaged in 
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each activity, possible answers were subjective such as “often” or “very frequently”. 
Respondents’ answers could have varied greatly depending on their own perceptions of how 
frequently they engaged in the activities that this study investigated. 
There are a few studies that cover this topic focusing on the more general population of 
psychotherapists, some of which include social workers. The Hansen-Grant and Riba study from 
1995 is an earlier study that examined communication between psychiatric resident physicians 
and psychotherapists over a five-month period. Data was gathered from quantitative surveys 
filled out by 13 psychiatric residents and patient charts. The surveys asked residents about the 
frequency and types of communication that they had with psychotherapists. The study concluded 
that communication between psychiatric residents and therapists was not adequate, due to it 
being irregular, infrequent, and inconsistently documented. Being over fifteen years old and 
based on a very limited and small sample, it would be very worthwhile to look again at some of 
the questions that this study aimed to answer. 
Another study that looks at the relationship between psychopharmacology and 
psychotherapy practice is the Springer and Harris study (2010) that examined licensed Marriage 
and Family Therapists' (MFTs) attitudes towards this subject and how they would act in a 
hypothetical situation. This study used a randomized sample of 322 respondents who were blind 
to the study's purpose. All participants were asked to read a clinical vignette, then give their 
impressions on diagnosis and what direction to proceed in with treatment. The goal was to look 
at which clinicians would refer the client in the vignette for medication consultation. A three part 
mixed-method questionnaire was used that included open-ended questions about participants’ 
beliefs, demographic questions, and a Likert-scaled quantitative section that asked more specific 
questions about participants’ beliefs and attitudes. Only 35.7% of the participants said that they 
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would refer the client in the vignette for a psychiatric medication consultation, even though the 
researchers designed the vignette to appear as though a consultation was probably indicated 
based on current evidence based literature. Twenty-six percent of the clinician respondents failed 
to explicitly diagnose the client in the vignette with major depression, even though it was 
determined through focus groups during the design phase that the vignette clearly portrayed a 
client suffering from symptoms specific to major depression. While using a vignette is a creative 
way to approach clinicians' attitudes and beliefs, this study did not account for all variables that 
could have affected participants' responses. One thing that the study should have explored more 
is the assessment and decision-making that the respondents used before determining their 
diagnostic impressions and whether or not to refer for medication, since the responses to the brief 
clinical vignette did not capture this. Respondents might have followed the belief that a 
preemptive diagnosis or referral could be stigmatizing without further exploration or rapport 
building.  
The Avena and Kalman study (2010) explored the topic of communication between 
psychotherapists and psychopharmacologists. A total of 53 non-prescribing psychotherapists 
were recruited through a Cornell University listserv and snowball sampling. They were mailed a 
brief quantitative questionnaire that questions about respondents caseloads, work experience, and 
the frequency at which they communicate with their clients' psychotropic medication prescribers. 
The study questions used in this questionnaire were very specific to just communication with 
prescribers, and did not leave room for respondents to elaborate on their experiences and 
perspectives since they were purely quantitative. This study found that of the 434 patients on 
psychotropic medication, for 22% of these cases there was no communication between therapist 
and prescriber. The statistical significance of the findings from this study is unclear and not 
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mentioned in the results section, so it appears that it was primarily a descriptive study. The goals 
of my study go beyond this by looking for statistically significant relationships between social 
worker communication and other descriptive variables. 
Study Goals Based on the Literature 
Ultimately, the goal of this study is to begin to build on the research of social worker's 
relationships with psychopharmacology because this is an area where there is a lack of empirical 
data. Since it also is an area that seems to lack a significant research base, studying this subject 
might open up new avenues of discussion. Based on this review of the literature, there are no 
studies that investigate the relationships between clinical social workers’ own perspectives on 
medication, their related interventions in treatment, and the frequency and quality of their 
communication with providers who prescribe psychotropic medications.  This study aims to 
investigate some of the relationships between all of these topics in the realm of split-treatment 
psychotherapy practice. Since there is a general lack of empirical literature in this area, there is 
also a need for this study to be more exploratory in nature, since there is a possibility many 









This is a cross-sectional, mixed-method, descriptive and exploratory study that addresses 
the question of "How do social workers in private practice view the role of psychotropics in 
treatment and handle psychopharmacological issues in practice?” As a result, its goal is not to 
investigate causality, only description and exploration of the issues within this topic are of 
interest. The study is mixed-method because the survey can provide both quantifiable data, while 
also allowing for responses that provided greater depth and variation within the open-ended 
questions. Having more exploratory open-ended questions was further reinforced by the reality 
that there is not a great deal of current research on the topic of social workers’ relationships with 
psychopharmacology and previously validated assessment tools. 
Sample: 
 Inclusion criteria required that participants were licensed to independently 
practice as clinical social workers at a master’s level. They also had to provide psychotherapy 
within a private practice format as opposed to working within a larger human services or mental 
health agency. The last criterion was that they must work with individual clients over the age of 
18. This was a nonprobability convenience sample. Since this sample was generated for a mixed-
method study and elements from the population do not have an equal chance of selection, it is 
not representative of the general population. Instead, the goal was to undertake an exploration of 
the experiences and perspectives of this group of respondents. 
18 
 
The initial sampling frame was all clinicians on the MBHP website. The MBHP website 
was selected as a starting point for recruitment in an effort to obtain a more diverse sample that 
works with more economically marginalized populations, since MBHP is made up of providers 
who provide mental health care for those who cannot afford private insurance. Many MBHP 
providers provide services to individuals with private insurance as well. If an individual who I 
contacted was interested in participating in the study, I asked for his or her email to send a link to 
the internet survey, or a physical mailing address to send a paper copy of the survey. I contacted 
all of the licensed clinical social workers on the MBHP website who listed working phone 
numbers. The total was 222. Approximately ten percent of the MBHP providers expressed 
interest in participating, so I had to expand the scope of my sampling in order to reach the goal of 
50 participants. As a result, I contacted 225 New England providers through the Psychology 
Today provider website were also contacted using their publicly available phone numbers and 
email addresses. A snowball sampling method was also used in order to generate a larger sample. 
For the snowball sample, participants who had already volunteered to help complete the survey 
were asked to generate other contacts. Using Psychology Today and snowball sampling 
expanded the geographic region from which the original sample was to be derived, and also 
expanded the sample social workers who were not MBHP members. The disadvantage of the 
sampling methods used in this study is that this sample is not representative of the general 
population of social workers in private practice. The strength is that the MBHP providers who 
cover underserved populations were given the opportunity to participate. This sample is mostly 
restricted by geographic location within New England and individuals and associates of those 




 A paper list of participant candidates was generated during the recruitment phase 
though the MBHP and Psychology Today websites  and particiapnt referrals through the 
snowball sampling method. This list was used to keep track of how and when each candidate was 
contacted and invited to participate. This list remained secured in a locked file and was only 
viewed by myself. It was destroyed after data collection was completed. 
Most of the data was collected via an anonymous internet-based survey with the 
SurveyMonkey platform. SurveyMonkey was selected over other internet survey platforms 
because it is the preferred internet survey tool at the Smith College School for Social Work due 
to the anonymity safeguards that it provides by disguising the IP addresses of participants. 
Participants were also given the option of completing a paper-based survey as an alternative to 
the internet survey. The paper-based survey included the same informed consent and questions as 
the internet survey. It was mailed to participants with a self-addressed stamped return envelope. 
A total of 12 surveys were completed by pen and paper. 
 Participants were instructed to not include their return addresses with completed surveys 
in order to preserve anonymity. SurveyMonkey and paper-based surveys also did not ask for any 
identifying information. For return addesses that were accidentaly included, I removed and 
destroyed all identifying information such as names or agency names from return envelopes for 
the paper-based surveys. Informed consent forms were removed from paper-based surveys and 
kept in a separate location. I entered the the data from each completed paper-based survey into 
SurveyMonkey. Written responses to qualitative questions were transcribed word-for-word. At 
this point all of the data was stored within SurveyMonkey, therefore it was anonymous through 
the use of SurveyMonkey’s anonymity safeguards. My research advisor, Jennifer Perloff was 
given access to quantitative data in the form of a SurveyMonkey excel file and the qualitative 
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data from open-ended questions after I removed all identifying information. Complete copies of 
the IRB application and informed consent form are included in the appendix section at the end of 
this report. 
The main data collection instrument for this study was a survey of my own design, which 
was created to gather qualitative data, quantitative data, and some demographic data on each of 
the participants. Some of the survey tools covered in the literature review section of this paper 
served as informal foundations for this survey tool, with this survey going into more depth 
regarding the frequency and nature of provider communication. “Section A”, the demographic 
section, asked participants to specify their age, sex, race, years practicing psychotherapy, 
treatment modalities used, practice setting, caseload, primary issues of focus, and percent of 
clients currently taking psychotropic medications. For demographic questions where it was not 
feasible for me to list all possible answers, the option of “other” was provided as an answer 
choice, along with a space for participants to specify what their response was. Following the 
demographic data, the survey had two separate sections of questions. The first section, “section 
B”, inquired about social worker’s working relationships with prescribing providers, while the 
next section, “section C”, specifically addressed social workers’ perspectives on the use and 
helpfulness of psychotropic medications. A complete copy of the survey instrument is included 
in appendix D of this report. 
Qualitative questions were all open-ended so as to give participants the change to 
elaborate into some depth about their perspectives and experiences. In order to account for 
possible omissions that could affect the results of qualitative data, the “Is there anything else?” 
question was included at the end of sections B and C. Sections B and C each contained 
qualitative questions, with a total of six for the entire survey. Quantitative questions were present 
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in all sections in multiple-choice format. For quantitative questions addressing “helpfulness”, 
Likert scales were used with possible responses being “strongly agree, agree, disagree, strongly 
disagree, and not sure”. Multiple choice questions in section B asked participants to specify how 
many of each type of prescribing provider they communicated with, the frequency of this 
communication, and social workers’ perspectives on the relative helpfulness of different types 
prescribing providers. Section C asked participants to specify how helpful they felt psychiatric 
medications were for different diagnoses of mental illness. 
 The main risks of participation in this study were emotional stress as a result of 
answering the survey questions and the possibility of breach of confidentiality. Some of the 
survey questions asked participants do describe their beliefs and subjective experiences 
regarding the provision of psychotherapy and working with other mental professionals, which 
some participants may have found stressful. Participants had the option of discontinuing the 
survey at any time in order to minimize this risk. To address the issue of confidentiality, 
participants were not asked for identifying information on any of the actual surveys (both mailed 
and internet). Participants were not provided with referral information for support services since 
they were all licensed mental health professionals. 
Analysis: 
Once all of my data was gathered and ready for analysis, open coding was used to 
categorize the qualitative data for themes that were analyzed at a greater depth. All qualitative 
data was collected and recorded as written text in Excel spreadsheets. Common themes were 
then analyzed using frequency distribution. When initially pulling for themes from the 
qualitative data, open coding was appropriate for this study because I did not have a clear picture 
of what themes I will find in the responses, so being able to create new categories for themes as I 
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went along was necessary. Data was grouped in such a way that it could be linked back to its 
original context in the written responses in order to allow for re-examination. Responses were 
read multiple times in order to maximize quantitative data yield.  
In the quantitative data section, correlation of Likert-scale responses with each other 
and/or other demographic data was also used to shed light on ideas for hypotheses on how 
respondents’ perspectives, behaviors, and demographics might relate. This was accomplished by 
using simple descriptive statistics and Spearman correlations, by comparing grouping variables 
from the demographics or Likert-scale topics with other test variables from Likert-scale topics. A 
relationship was considered statistically significant if the p value was lesser than or equal to 0.05. 
One example included clinicians' frequency of communication with psychiatrists and their 
perspectives on the “helpfulness” of psychotropic medications with clients with serious mental 
illness. Weaknesses with this type of analysis include the possibility of a sample that is too small 
to generate statistically significant relationships, the subjectivity and variation of responses that 
occurs with Likert scales, and the fact that the diversity of the sample will be skewed by 
recruitment methods. Since my total sample is fairly small (56) and limited by snowball 
sampling, generalizable quantitative correlations could not made between respondent 
demographics and their responses. The goal of both the qualitative and quantitative data analysis 
was to expand the knowledge base of the kinds of experiences that social workers in private 
practice encounter with respect to medication issues. 
My own personal bias regarding psychotropic medication could have affected the results 
of this study, since it is a topic that I have some strong personal opinions about. Since I created 
my own survey, it was very important for me to scrutinize my questions to avoid possible bias. 
In order to account for possible omissions that could affect the results, I asked a few of my 
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student peers and two clinical research professionals for feedback on my survey. Having the “Is 
there anything else?” question as the last qualitative question was also designed to help to 








This chapter summarizes the findings from a mixed method survey (Appendix D) that 
was designed to explore clinical social workers perspectives on the helpfulness of psychotropic 
medications, major issues that they encounter in practice when discussing psychotropic 
medications with their clients, and the nature of their communication with prescribing providers 
of psychotropic medications. This first part of this chapter will present the quantitative 
demographic data retrieved from the study, followed by quantitative and qualitative data from 
Section A and B of the survey. Lastly, the chapter will cover correlational findings based on 14 
variables created from quantitative data. 
Descriptive Findings: 
Respondent Demographics. There were 66 total responses to the internet and paper 
based survey tools in this study, but the data from only 56 was used. 10 respondents were 
excluded from the study because they did not meet exclusion criteria requirements or did not 
complete any survey questions beyond the initial screening questions. Of the sample of 56 
official respondents, the average age was 58.9 years, with the youngest respondent being 34 
years old and the oldest being 79 years old. Fifty-eight point nine percent identified their sex as 
female and 41.1% identified their sex as male, which is a diverse sample in terms of sexual 
identity, considering that the majority of clinicians who were contacted during the recruitment 
phase were female. The sample was not diverse in terms of racial identity, with 100% of the 
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respondents identifying as white. Fifty-five of the respondents listed the number of years they 
had practiced psychotherapy, with a response average of 26.4 years, the least being 4 years and 
the most being 48 years.  Fifty-six of the respondents specified the setting of their practice, with 
14.3% in rural areas, 41.1% in suburban areas, and 44.6% in urban areas. 
Table 1 
Demographics of the Respondents 
Age Average 59.8 years
 Minimum 34.0 years
 Maximum 79.0 years 
 
Sexual Identity Female 58.9%
 Male 41.1%
 
Racial Identity White 100.0%
 






Average 26.4 years 
 Minimum 4.0 years
 Maximum 48.0 years
 
The treatment techniques used by respondents are listed below on Table 2. Out if the 56 
respondents, they most frequently listed cognitive behavioral therapy (89.3%), psychodynamic 
(69.6%), and then eclectic (55.4%) as treatment techniques used in practice. In addition to the 
three most frequently used techniques, respondents specified quite a variety of other techniques 
that they use in practice, including coaching (25.%), dialectical behavior therapy (26.8%), eye 
movement desensitization and reprocessing (26.8%), family systems (14.8%), humanistic 
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(35.7%), mindfulness based cognitive therapy (46.4%) and psychoanalytic (19.9%).  Treatment 
techniques that were specified by less than 10% of the respondents are not included in the results 
on Table 2. In this section, most respondents listed three or more techniques, suggesting that 
most of the respondents were “eclectic” to some extent. 
Table 2 
Treatment Techniques of the Respondents 
 
Treatment Technique Percent of respondents who use technique 
(n=56) 
Coaching 25.0%
Cognitive Behavioral Therapy (CBT) 89.3%
Dialectical Behavior Therapy (DBT) 26.8%












Looking at caseload demographics listed below on Table 3, Respondents had an average 
caseload size of 42 clients, with the smallest caseload being 6 clients and the largest caseload 
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being 150 clients. Forty-seven respondents listed the three most prominent issues of focus with 
their clients. Of these 47 respondents, 89.4% reported that depression was a major issue of focus 
in treatment with clients, followed by anxiety at 74.5% and relationships at 47.7%. Only one 
respondent (2.1%) listed psychosis as a major issue of focus, this being the least prominent issue 
among the respondents. There was a fair amount of variation within the question that addressed 
percentage of caseload taking psychotropic medications. The majority of respondents (50.9%) 
stated that approximately 26%-50% of their caseload is on psychotropic medications. This was 
followed by 36.4% of respondents stated that 51%-75% of the caseload is on medication, 7.3% 
stated that 76%-100% of their caseload is on medication, and the least number of respondents 
(5.5%) stated that less than 25% of their caseload is on medication. Other issues that were listed 
by less than 10% of respondents are aging, disability, grieving, personality disorders, psychosis, 




Number of psychotherapy clients 






Major issues of focus in caseload 
n=47 
Addiction/Substance Abuse (11) 23.4%
 Aging (2) 4.3%
 Anxiety (35) 74.5%
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 Depression (42) 89.4%
 Disability (1) 2.1%
 Grieving (3) 6.4%
 Personality Disorders (3) 6.4%
 Psychosis (1) 2.1%
 Relationships (22) 46.7%
 Sexual/Gender Identity (2) 4.3%
 Spirituality (2) 4.3%
 Trauma (16) 34.0%
 Other (4) 8.5%
 
Percent of caseload taking 
psychotropic medications n=53 
Less than 25% (3) 5.5%
 26%-50% (28) 50.9%
 51%-75% (20) 36.4%
 76%-100% (4) 7.3%
 
Main descriptive findings. The descriptive findings came from section A and section B 
of the survey, which addressed the respondents working relationships with prescribing providers 
and then their own perspectives regarding psychotropic medications, respectively. 
Provider communication: Quantitative findings. The quantitative data on working with 
providers of psychotropic medications is listed below in Table 4.  For the survey question that 
asked participants to specify the “helpfulness” of different types of providers, 68.6% of 
respondents specified that they agreed that psychiatrists are helpful, and 64.7 % specified the 
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same with regard to primary care doctors. Only 3.9% of respondents disagreed that psychiatrists 
are helpful, whereas 11.8% disagreed or strongly disagreed with the helpfulness of primary care 
doctors. For the category of psychiatric nurse practitioners and psychiatric physician’s assistants, 
the majority of respondents (48.8%) specified that they strongly agreed that these types of 
providers are helpful, while a total of 6% either disagreed or strongly disagreed. For primary care 
nurse practitioners and physician’s assistants, the majority of respondents (42.9%) specified that 
they were not sure of the helpfulness of these types of providers, 47.0% agreed or strongly 
agreed that they are helpful, and 11.9% disagreed or strongly disagreed that they are helpful. 
These results are based on the types of practitioners that the respondents worked with in practice, 
so the sample size varied between each of these statistics. 
The second section of Table 4 shows the results from respondents who communicate with 
the corresponding prescribing providers at least once a month. These results give a different 
picture from the above results, showing that psychiatric nurse practitioners physicians assistants 
are rated more favorably than the other types of providers, with 12 out of 21 respondents (57.1%) 
selecting strongly agree for helpfulness in this category. For the category of primary care nurse 
practitioners and physicians, the majority of respondents (7 or 53.9%) listed that they disagree 
with the helpfulness of these providers. The majority of responses did not change for 
psychiatrists and primary care doctors, since 64.7% of respondents for each type of provider 
stated that they agree that they are helpful. 
Table 4 
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(3) 23.1% (3) 23.1% (7) 53.9% (0) 0.0% (0) 0.0% 
 
Table 5 lists findings from questions that addressed the frequency of respondents’ 
communication with prescribing providers. When looking at the frequency of communication 
with specific providers, the majority of respondents specified that they communicate less than 
once a month with each type of prescribing provider, ranging from 40%-60%. Within all of the 
different prescribing provider categories, the lowest number of respondents specified that they 
communicate more than once a week (only one respondent per category, 1.9%-2.9%).  The last 
two sections of this table look at communication frequency depending on the “severity” of 
mental illness. The majority of clinicians specified that they communicate on average of one 
time every three months with prescribing providers of clients who have “mild to moderate 
mental illness” (37.7%) and “more serious mental illness” (44.9%). In general, respondents 
tended to communicate more frequently regarding clients with more serious mental illness 
compared to communication regarding clients with mild to moderate forms of mental illness. 
Table 5 
























































Working with Providers of Psychotropic Medications- Frequency of Communication 
Average frequency of 
communication with prescribing 
providers for clients with mild to 
moderate mental illness n=51 
More than 1x per week (0) 0.0%
 1x per week (1) 2.0%
 1x per month (8) 15.7%
 1x every three months (19) 37.7%
 1x a year or less (23) 45.1%
Average frequency of 
communication with prescribing 
providers for clients with serious 
mental illness n=52 
More than 1x per week (0) 0.0%
 1x per week (4) 8.2%
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 1x per month (12) 24.5%
 1x every three months (22) 44.9%
 1x a year or less (11) 22.5%
 
Provider communication: Qualitative findings.  
Provider inaccessibility. In the open response questions of the survey Section A, the most 
common issue was that prescribing providers are not accessible for communication about cases, 
which 29 out of 56 or 51.7% of the respondents wrote about. This may include a lack of regular 
responses to voicemail messages, or statements that prescribing providers are “too busy”. A 
typical response that came from one of the respondents regarding this issue is that “prescribers 
rarely contact me or respond to written requests for information”. Another respondent stated, 
“The most common issue in dealing with a client's prescriber is the ability to actually talk to 
them.  Coordinating care with a PCP who is hard to get a hold of, is screened by a nurse, and is 
often (meeting) with a patient like I am.” This response also touches on second most common 
issue that respondents wrote about, which is that it is difficult to find time to communicate with 
prescribing providers. This was often due to scheduling conflicts since providers cannot 
communicate with each other when meeting with clients.  The theme of “not having enough 
time” was present 11 out of 56 or 19.6% of the responses.  
 Four respondents wrote about the supply of prescribing providers not being adequate, 
specifically providers who focus on psychiatric medications such as psychiatrists and psychiatric 
nurse practitioners.  A comment that illustrates this from a social worker describing a group of 
approximately 10-15 clients from her caseload taking psychotropic medications; “Only one of 
my patients sees a psychiatrist for meds. There are hardly any in this area and those that are do 
not want to simply prescribe.” 
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Conflicting views. Eight of the respondents (14.3%) described generally having 
conflicting views with the types of treatment provided by prescribers. Actual respondent 
statements pertaining to this theme include “I would like to see the medical profession take more 
of an interest in therapy which does not use psychotropics”, “On a number of occasions, there 
have been problems with lack of responsiveness to the acuity of situations regarding suicidal 
ideation.” and “(I) Sometimes feel that psychiatric providers do not explain enough to clients or 
listen to clients' complaints with respect to the meds they are on.” Respondents also wrote about 
not agreeing about the types of medication prescribed to their clients. Three respondents wrote 
specifically about the issue that prescribing providers are too focused on formulating clients’ 
cases using biological perspectives and often disregard the psychological and social factors 
contributing to clients’ mental illnesses, such as “ignorance of intrapersonal and interpersonal 
issues of client”. The theme of polypharmacy or being prescribed too much of certain types of 
medication was mentioned by two respondents.  
 Relationships with specific types of prescribing providers. Two of the respondents 
reported that psychiatric nurse practitioners were particularly helpful. One even stated that that 
they are “Godsend”. Another respondent wrote about relationships with Obstetrician-
Gynecologists, describing their role in prescribing psychotropic medications as helpful; “I 
receive many referrals from Ob-Gyns v. PCPs.  The Ob-Gyns tend to be more tuned in to their 
patients; also, the nature of the reasons for patients' visits to Ob-Gyns is often emotionally 
charged (pregnancy, miscarriage, menopause, infertility, disease, etc.), so those doctors end up 




Adequacy of prescribing providers. Five respondents stated that prescribing providers 
who are not psychiatrists or who do not specialize in psychiatric medicine do not have adequate 
knowledge or experience to prescribe psychotropic medications, including one respondent that 
made this statement regarding primary care practitioners; “some of whom have little 
understanding of the benefits of individual antidepressants, meaning it is not unusual to see the 
patient prescribed "the wrong" or less effective med, or start patients at full doses when titration 
up would limit side effects that are often temporary. Intense side effects in beginning equals non-
compliance and fear of meds.”  Two respondents wrote that they are “uncertain” of whether or 
not their clients’ prescribing providers perform adequately. 
Other issues that come up when working with prescribing providers. In section A of this 
survey, six (10.7%) of the respondents reported that they feel like their input is not respected 
and/or valued by prescribing providers. The same number of respondents emphasized that 
teamwork is important in order to provide the best care for clients. Two respondents mentioned 
having general issues with continuity of care, while two other respondents emphasized that 
adequate communication does occur when a client is in crisis. When having collaborative 
discussions about the efficacy of medication, two respondents stated that the general inefficacy 
of medication is a common theme. Four respondents mentioned that finding adequate 
medications for clients with substance abuse issues is something that they frequently have to 
troubleshoot with prescribing providers. 
Work with clients and psychotropics: Quantitative findings. The quantitative question 
from the survey Section B on social workers views of psychotropic medications asked clinicians 
to specify their level of agreement with the helpfulness of psychotropic medications depending 
on the type of mental illness symptoms that clients struggle with. Overall, respondents tended to 
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agree or strongly agree that psychotropic medications are helpful for each of the symptoms. For 
mild to moderate anxiety, 11.3% strongly agree and 62.3% agree with the helpfulness of 
psychotropic medications.  Nine point four percent disagree and 3.8% strongly disagree with the 
helpfulness of medications, while 13.2% said they were “not sure”. For severe anxiety, 94.3% 
either agree or strongly agree with the helpfulness of medications. For mild to moderate 
depression 75.5% agree or strongly agree with the helpfulness of psychotropic medications, but 
94.3% either agree or strongly agree when clients struggle with severe depression. For mood 
instability, 86.8 of respondents agreed or strongly agree, 3.8% strongly disagree, and 9.4% are 
not sure with the helpfulness of psychotropic medications.  Lastly, for psychotic symptoms 
82.7% of respondents agree or strongly agree with the helpfulness of medications and 13.5% are 
not sure.  
Table 7 
Social Workers’ Perspectives on Psychotropic Medications 
Psychotropic 
medications 












(6) 11.3% (33) 62.3% (5) 9.4% (2) 3.8% (7) 13.2%
Severe 
anxiety n=53 
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(30) 57.7% (13) 25.0% (1) 1.9% (1) 1.9% (7) 13.5%
 
Work with clients and psychotropics: Qualitative findings.  
Side effects. The issue that respondents mentioned the most frequently when writing 
about work with clients is the topic of side effects caused by psychotropic medications. Thirty of 
the fifty-six respondents (53.5%) mentioned side effects being problematic at some point within 
the open-ended responses of Section B. Some specific side effects that were mentioned include 
“fogginess”, “weight gain”, “dry mouth”, inability to cry”, and reduction of “sexual 
functioning”. Within many of these responses, it was noted that side effects contribute to clients’ 
fears of starting and/or staying on medications, or complying with medication regimens.  
Fears and stigma. The next most frequently reported issues are regarding clients’ fears of 
being on medication. Fourteen respondents (25.0%) wrote that general “fears” of being on 
medication are an issue in treatment. The same number of respondents mentioned that dealing 
with emotional and social stigma or processing the fear of emotional and or social stigma is 
problematic for clients who are either on medication or considering going on it, respectively. An 
good example from a respondent regarding this issue is, “The stigma attached to taking these 
medications is often internalized by clients who then tend to see their need for the medicine as an 
indication of weakness or defect.” Two respondents also reported that clients’ negative past 
experiences with psychotropic medications add to their fears of trying them again.  
The need for psychoeducation. Providing psychoeducation, helping clients who are 
misinformed and teaching clients how to advocate for themselves when discussing psychotropic 
medications in therapy were three different themes present in the survey responses. Six 
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respondents (10.7%) stated that psychoeducation about psychotropic medication was an 
important part of their work, which was often about helping clients to understand the positive 
and negative aspects of medications. Four respondents stated that their clients are often 
misinformed about medication, such as having the “incorrect information about course of 
treatment and side effects.” None of the respondents were specific about the sources of 
misinformation. Another related topic that five respondents wrote about was that many clients 
place expectations that are too high on their medication, such as wanting it to act quickly or 
eliminate all negative feelings. Lastly, seven respondents (12.5%) wrote about the importance of 
clients knowing how to be advocates for themselves when meeting with prescribing providers 
about psychotropic medications. One provider wrote about this regarding the issue of changes to 
the medication regimen, “People need to learn that they have to advocate for themselves and 
know that they must step down carefully when coming off meds. If a new provider wants to 
abruptly take them off a medication, the client must advocate for him- or herself and not just 
allow an abrupt change to be made.” 
Changing medications and dosages. Change in the medication regimen was another 
frequently mentioned issue in this section of the survey, specifically about how many clients 
struggle with their medication types and dosages being changed. Six (10.7%) the of respondents 
stated that this was an issue that their clients frequently bring up, especially because there are 
often multiple trials before many clients are on the best medication regimen.   
Building rapport. One respondent emphasized special consideration that is necessary 
when working with clients who struggle with more severe forms of mental illness, “Ironically, it 
is often the most ill patients that are most opposed to medication. It takes patience and building a 
rapport along with informing them about the increase in control of their thought and feelings that 
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will likely come from taking the medications”.  He emphasizes the need to build trust in order to 
help clients who are very resistant to taking medication as a result of their fragile mental states. 
Issues with the prescribing provider. Six respondents (10.7%) mentioned that they and 
their clients struggle with being satisfied by and/or trusting the collaborating prescribing 
providers. Some of the specific issues mentioned related to this topic include “ Being diagnosed 
without a comprehensive and collaborative assessment”, “Short sessions with prescribers leave 
clients feeling unheard”, “resistance of the MD to modify or change the med at the appropriate 
time”, and “Failure of the prescriber to be invested in the client’s real world struggles.” 
Professional boundaries. When some of the respondents encounter situations where they 
are questioning the prescribing provider’s actions, one of the common dilemmas that they 
mentioned was overstepping the professional boundaries of their roles as social worker-
psychotherapists. A total of nine (16.1%) of the respondents mentioned overstepping 
professional boundaries as an issue that they struggle with in practice. In one case, a respondent 
stated “Masters level clinicians can't legally recommend medications, so a fine line is often 
walked when a patient is not on an appropriate medication, or is over-medicated. The fine line is 
how not to anger prescribers (most often primary care docs) and still get the point across.” 
Another statement that shows a more guarded perspective is, “I am very cautious about 
discussing meds with patients. I am a LICSW and, as such, I feel that more than a suggestion of 
referral/med check is outside my sphere of professional competence.” 
The need for more holistic perspectives and approaches.  Seven respondents (12.5%) 
reported that their clients focus too much on the biological aspects of their treatment, specifically 
medications. As a result of this, they do not give enough credit to improvements that they have 
made as a result of hard work in psychotherapy. Or, they may come to psychotherapy as a 
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formality when they really feel like medication is the only thing that is helping or will help them. 
Two respondents emphasized the need for more holistic types of treatment that incorporate 
interventions that are not traditionally a part of psychotherapy. Possibilities include incorporating 
“meditation”, “breathing techniques”, “nutrition”, and “exercise”. 
Other barriers to pharmacotherapy. Two other major barriers to pharmacotherapy that 
respondents pointed out included clients’ struggles to be compliant with their medication 
regimens and monetary issues associated with psychotropic medication. Compliance issues that 
were highlighted by five respondents include, coming off medications (against medical advice) 
as a result of “a desire for more autonomy”, not “taking meds as prescribed” and struggling with 
“abstinence from alcohol and other drugs”.  Three respondents mentioned that money was an 
issue, stating that the additional cost of medications to clients and lack of therapist 
reimbursement for time spent collaborating with prescribing providers prevent clients from 
getting the best treatment. Two of the respondents reported that health insurance company 
policies cause some of these issues. 
Correlative findings: Fourteen variables were analyzed for statistically significant relationships 
using the Spearman’s rank correlation coefficient. The variables are: caseload; years practicing 
psychotherapy; therapy count (total number of therapeutic techniques a respondent uses); percent 
of caseload on medication; frequency of communication with psychiatrists; frequency of 
communication with primary care physicians; frequency of communication with psychiatric 
nurse practitioners and physicians assistants; frequency of communication with primary care 
nurse practitioners and physicians assistants; frequency of communication with prescribing 
providers of clients with mild to moderate mental illness; frequency of communication with 
prescribing providers of clients with serious mental illness; helpfulness of psychiatrists; 
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helpfulness of primary care doctors; helpfulness of psychiatric nurse practitioners and physicians 
assistants; and helpfulness of primary care nurse practitioners and physicians assistants. These 
correlation figures can be found in Table 7.   
Looking at the caseload variable, one statistically significant weak correlation was found 
in relation to respondents’ frequency of communication with prescribing providers of clients 
with serious mental illnesses. This was a negative correlation of about -0.33, so higher caseload 
numbers corresponded with lower communication frequencies. There were two statistically 
significant correlations with the age variable, both of which were also negative. These showed 
relationships between the respondent’s age and their perception of how helpful psychiatrists or 
psychiatric nurse practitioners and physician’s assistants are to their clients, with correlations of -
0.37 and -0.32, respectively. This means that older respondent age corresponded with 
perceptions of psychiatrists and psychiatric nurse practitioners/physicians assistants being less 
helpful. For the percentage of respondent caseload on medications variable, negative statistically 
significant correlations were found between this variable and helpfulness of psychiatric nurse 
practitioners/physicians assistants along with communication frequency with primary care nurse 
practitioners /physicians assistants. The correlations for these were Rho= -0.32 and Rho= -0.39, 
respectively. 
Statistically significant positive correlations were found between all of the psychiatrist, 
primary care doctor, and psychiatric nurse practitioner communication frequency variables. The 
strongest correlation was between psychiatrist and psychiatric nurse practitioner/physicians 
assistant communication frequency (Rho=0.59), followed by psychiatrist and primary care doctor 
communication frequency (Rho=0.46), and primary care doctor and psychiatric nurse 
practitioner/physicians assistant communication frequency (Rho=0.36).  There was no 
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statistically significant correlation between primary care nurse practitioner/physicians and 
psychiatrist communication frequency. But, there were significant correlations between primary 
care nurse practitioner/physicians assistant and primary care doctor communication frequency 
along with primary care nurse practitioner/physicians assistant and psychiatric nurse 
practitioner/physician assistant communication frequency. Correlation values for these were 
Rho=0.49 and Rho=0.61, respectively.  
Respondent communication frequency with prescribing providers of clients with mild to 
moderate mental illness and serious mental illness showed significant positive correlation with 
respondent communication frequency with psychiatrists, primary care doctors, and psychiatric 
nurse practitioners. There was no statistically significant correlation between these two variables 
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 This study explored the perspectives and experiences regarding psychopharmacological 
issues of social workers working as private practice psychotherapists. It specifically focused on 
their own perspectives on the helpfulness of medications for their clients and the nature of their 
professional relationships with prescribing providers. It used a mixed-method survey comprised 
of multiple choice and open ended questions (Appendix D) that asked participant social workers 
to describe their own perspectives on the helpfulness of psychotropic medications, issues that 
arise when discussing psychotropic medications with their clients, issues that arise when working 
with prescribers of psychotropic medications in split treatment, and the frequency of their 
communication with prescribing providers. 
The results from this study suggest a few important possibilities. First is that most private 
practice social workers believe that psychotropic medication is helpful, with the degree of 
helpfulness varying depending on the nature of the client’s mental illness. Second, social 
workers observe that their clients struggle with a multitude of conflicts affecting their 
willingness to be treated with psychotropic medications. Third, social workers in private practice 
find that communication difficulty between prescribing providers frequently has a negative 
impact on treatment. This includes not being able to communicate frequently enough with 
prescribing providers, not agreeing with prescribing provider’s treatment strategies, and not 




Social Workers Working with Prescribing Providers 
Communication frequency. Kahn (1991) emphasizes that an effective split treatment 
relationship must have productive collaboration and communication between all members. In 
this study, members consist of the client, the social worker, and the prescribing provider. Despite 
the importance of effective communication, the results from this study suggest that the nature of 
communication is not adequate. Both the Hansen-Grant and Riba (1995) and Avena and Kalman 
(2010) studies investigated the frequency of psychotherapists’ communication with prescribing 
providers, and both concluded that the communication between providers was not frequent 
enough for adequate treatment, with Avena and Kalman finding that 22% of their respondents 
did not communicate with prescribing providers at all. In the Bentley, Walsh and Farmer 2005 
study, 46% of the respondents listed that they communicate with prescribing physicians “very 
frequently”. Since “very frequently” is a subjective measure of frequency, it is hard to assess. My 
study also suggests that provider communication is not frequent enough. Forty-five point one 
percent of respondents stated that when treating clients with mild to moderate mental illness, 
they communicate with prescribing providers once a year or less. When treating clients with 
serious mental illness, the majority of respondents (44.9%) stated that they communicate with 
prescribing providers every three months on average, and 22.5% stated that they communicate 
with prescribing providers once a year or less.  
Some respondents elucidated possible barriers to more frequent communication in the 
open-ended response sections of the survey. The most frequently mentioned issue was that 
prescribing providers are hard to reach. Reasons for this include that they have busy schedules 
and are not able to regularly follow up on phone calls and written requests to share information. 
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Another possible barrier to communication frequency is the fact that many of the respondents 
stated that that their own schedules were too busy in order to take time out of the workday to 
contact other providers. One respondent mentioned the lack of reimbursement for time spent 
outside of psychotherapy sessions is an issue, which could deter social workers from initiating 
more frequent communication from prescribing providers. 
Another possible cause of infrequent and ineffective communication may be a lack of 
interest in social workers’ input on the part of prescribing providers. A significant number of 
respondents (10.7%) felt like their input was not valued by prescribing providers, which might 
cause them to put less effort into reaching out. If a significant number of prescribing providers 
do not value input as these respondents have experienced, the prescribing providers may also be 
much less likely to communicate frequently with social workers. Disagreement over how to treat 
clients could also add to this dynamic if it results in shutdown of communication. This is also 
important to consider because 14.3% of respondents in this study mentioned that disagreement 
with prescribing providers is a significant issue in practice. 
Statistically significant communication frequency correlations. Another significant 
finding related to the issue of communication frequency is that there was a weak negative 
correlation between social workers’ caseload size and their communication frequency with 
prescribing providers of clients with serious mental illness. This means that social workers with 
larger caseload sizes tended to communicate less with prescribing providers regarding clients 
with serious mental illness. Although this is a weak correlation within a relatively small sample 
size, the implication of this is very important because it could mean that when social workers 
have large caseloads, the neediest clients are getting less help and support compared to clients 
with more mild forms of mental illness. 
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Positive correlations were found between almost all of the provider-specific 
communication frequency variables, except for communication frequency with psychiatrists and 
primary care nurse practitioners/physicians assistants. The statistical significance of the 
relationship between these two variables was probably affected by the very small sample of 
respondents who communicate regularly with primary care nurse practitioners and physicians 
assistants. Given a larger sample, it is possible that a statistically significant relationship may 
have been found. The trend of significant positive correlations between all of these variables 
ranges from correlations of Rho=0.36 to Rho=0.61. Explaining the reasons behind the 
differences in these variables is beyond the scope of this study, but it appears that if a social 
worker communicated frequently with one type of prescribing provider, it is likely that she 
communicated frequently with other providers as well. 
Prescribing provider helpfulness. Social workers perceptions of the “helpfulness” of 
different types of prescribing providers was another variable that this study investigated in order 
to evaluate the adequacy of split treatment relationships. In the case of respondents who 
communicated with prescribing providers at least once a month, 57.1% of those who worked 
with psychiatric nurse practitioners and physicians assistants stated that they “strongly agreed” 
that these types of providers were helpful and supportive to clients, whereas the majority of 
respondents working with psychiatrists and primary care doctors stated that they “agreed” with 
the helpfulness of these providers (64.7% in both cases). In the qualitative response section of 
the study, two respondents also wrote that they find psychiatric nurse practitioners to be 
particularly helpful.  Primary care nurse practitioners and physicians assistants were perceived to 
be the least helpful, with the majority of respondents (53.9%) stating that they “disagree” that 
these types of providers are helpful. To understand the exact reasons behind these findings would 
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require more exploration, but possible reasons for the non-physician psychiatric providers being 
more “helpful” could be a result of their training, which might teach them to look at client 
problems similar to the way that social workers are trained. Since these providers are non-
physicians, social workers may view them more as equals and therefore they might seem more 
approachable. Clients may also view them as more approachable for this reason. 
Statistically significant helpfulness correlations. There were weak negative correlations found 
between respondent age and the perception of helpfulness regarding psychiatrists and psychiatric 
nurse practitioners and physicians’ assistants, showing that younger participants tended to have 
more positive views of these prescribing practitioners helpfulness and supportiveness of clients. 
Determining the possible causes of this phenomena is beyond the scope of this study, but it is 
still significant if it is a phenomena that occurs on a more widespread level. It would be worth 
looking into factors that might influence this, including differences in educational background, 
culture, and attitude that are dependent on the historical timeframes that social workers have 
practiced in.  
The sample for each of these categories is small since a large group from the overall 
study sample size specified that they communicated with these types of providers less than once 
a month. But, the differences are significant enough that the topic of other providers’ 
“helpfulness” would be worth exploring in greater depth to see if this trend is more widespread, 
and possibly exploring reasons as to why the non-physician psychiatric prescribing providers 
might be the most helpful in split treatment relationships. Since these questions regarding 
provider helpfulness are quantitative but subjectively interpreted, they do not address how the 
respondents perceive the meaning of these concepts. Further research that addresses exactly what 
social workers perceive to be helpful and supportive could be worthwhile given the opportunity. 
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This could be beneficial to social work practice because it may uncover some of the issues that 
trigger a breakdown of split treatment relationships, and reasons why prescribing providers with 
certain types of training backgrounds might be more helpful than others. 
Social Workers’ Perspectives on Clients and Psychotropic Medications  
Helpfulness of psychotropic medications. It is clear that the majority of social workers 
in this study believe that psychotropic medications are helpful to adult clients with most forms of 
mental illness, including anxiety, depression, psychosis, and bipolar affective disorder. This is 
similar to the results from the 2006 Moses and Kirk and 2008 Moses studies regarding treatment 
of adolescents, since the general opinion of respondents was that psychotropic medication was 
more beneficial than harmful when used as treatment for mental illness in this younger 
population. Despite the mostly positive views of psychotropic medications, the responses from 
participants in my study and the Moses and Moses and Kirk studies are complex, since their 
views on the benefits and helpfulness of medication vary greatly depending on many different 
biopsychosocial factors that affect their clients.  
A qualitative question from the survey from this study asked participants to specify their 
level of agreement with the helpfulness of psychotropic medications depending on the type and 
severity of mental illness that their clients suffered from. The majority of respondents either 
agreed or strongly agreed with the helpfulness of psychotropic medications in treatment of mild 
to moderate anxiety, severe anxiety, mild to moderate depression, severe depression, mood 
instability and psychosis. The highest levels of agreement with the helpfulness of medications 
were present for severe anxiety and depression along with psychosis. The illness categories with 
the most disagreement of the helpfulness of psychotropic medications were mild to moderate 
depression and mild to moderate anxiety, where a total of 13.2% of respondents either disagreed 
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or strongly disagreed with the helpfulness of psychotropic medications for each of these two 
categories.  
Responses from qualitative questions may provide insight into the reasons why some 
respondents disagree or strongly disagree with the helpfulness of psychotropic medications for 
clients who struggle with less severe forms of depression and anxiety. Over half of the 
respondents mentioned that the side effects of psychotropic medications are frequently an issue 
in psychotherapy. Issues with dosage changes and needing multiple medication trials were also 
issues brought up by clients of some of the respondents. Because of this, side effects and other 
neurological/physiological issues affecting clients may have a negative influence on how social 
workers perceive the overall helpfulness of medications.  
Other issues from working with clients and psychotropics. Respondents in the open-
response sections of the survey mentioned some other issues that they frequently deal with in 
psychotherapy with clients who are considering or already taking psychotropic medications. 
First, was that clients’ perspectives regarding psychotropic medication were influenced by many 
different factors in addition to information from mental health providers and actual 
neurological/physiological effects. “Stigma” was frequently mentioned by respondents (25%), 
which pertains to the negative cultural stigma around having a mental illness and/or having to 
take medication for it.  
In addition to working with clients on the role of stigma, respondents also spoke about 
the difficulty of maintaining appropriate professional boundaries while still being able to help 
clients (16.1%), the importance of providing psychoeducation (10.7%) and helping clients to 
advocate for themselves (12.5%) regarding psychotropic medication issues. These findings 
emphasize the need for clinical social worker psychotherapists to have a solid foundation of 
51 
 
knowledge and ability to navigate difficult practice issues regarding the topic of psychotropic 
medications. They need to be able to provide their clients with basic information about 
medications since many clients might not have the ability to speak with a prescribing provider 
when needed. Social workers also need to be comfortable with knowing when a client’s needs 
are out of the scope of social work practice, and should be met with the help of a licensed 
prescribing provider. Without this foundation, clients will be at risk of abandonment and/or 
harmful interventions. Currently, social workers can obtain information on psychotropic 
medication facts and issues from school, trainings, research and colleagues trained in 
psychopharmacology. In order to provide their clients with the best treatment possible, it is 
imperative that they actively seek out this information throughout their careers. 
Study Limitations 
Major limitations of this study include the sample frame and size, the survey tool was a 
new and unproven instrument, and the survey only focused on the perspectives of social workers. 
Since the study’s sample frame was created using snowball sampling and the frame of MBHP 
and Psychology Today providers, it is not representative of the larger population. Self-selection 
bias is also a likely to have affected the results because social workers had the choice to accept or 
decline participation in the study. What this means is that group of social workers that declined 
may have responded differently to the survey, which would have created a different set of 
results. The sample size is also relatively small, also decreasing the likelihood that the results 
could represent the general population. Even though the survey tool was based somewhat on 
prior studies, it was still a new and unproven instrument that has not been rigorously tested to 
eliminate researcher bias. A strong social work perspective also limited the perspectives that 
respondents shared. Although it was by design, this study did not give prescribing practitioners 
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and clients a chance to share their own perspectives firsthand. Given the opportunity, it would be 
worth investigating this in the future.  
Implications for Social Work Practice 
One of the more disturbing findings from this study is that when treating clients with 
serious mental illness, social workers communicate less with prescribing providers as the size of 
their caseloads increases. What this means is that this particular vulnerable population may be 
getting lower quality treatment than other groups. This issue emphasizes the need to continue 
research on how socio-cultural and socio-economic factors may affect the quality of 
psychotherapeutic and psychopharmacological treatment that clients are receiving. Given the 
opportunity to continue this research, it will be imperative to look into how many other client 
caseload demographics, such as age, socio-economic status, race, type of health care coverage, 
and type of psychotherapeutic treatment being received affect the nature and quality of treatment 
regarding psychopharmacological issues. When looking at caseload demographics, it will also be 
necessary to take into account how non-client variables such as payers and local healthcare 
statutes since these variables may influence provider communication separate from client 
characteristics. It is the duty of social workers to advocate and provide for vulnerable 
populations, but it is clear that very little is known about the presence or lack of discriminatory 
treatment in this subject area.  
Based on the results from this study and the previous studies mentioned earlier in this 
chapter, it is becoming clear that there are significant barriers to communication between private 
practice social workers and prescribing providers. A majority of the respondents in this study 
highlighted how inaccessible prescribing providers and scheduling conflicts prevent 
communication from happening as frequently as it should. Furthermore, conflicts that arise 
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within professional split-treatment relationships can also prevent clients from getting the best 
treatment. Gutheil and Simon (2003) suggest that social workers create pre-treatment contracts 
with prescribing providers that outline each provider’s roles and responsibilities in treatment. 
Such contracts may help to maintain regular communication and prevent disagreements between 
providers that are detrimental to clients. This is another possible area of research where not much 
is known about how often social workers engage in such arrangements and how helpful they may 
be to both providers and clients. It is possible that social workers need more education on how to 
build effective split-treatment relationships. 
It also appears that social workers find certain types of prescribing providers to be more 
helpful for clients than other types, such as psychiatric nurse practitioners and physicians’ 
assistants. This study did not uncover any significant findings as to why this is, but this issue is 
extremely important because of how 94.5% of respondents in this study reported that more than 
25% of their clients were currently taking psychotropic medications. If these statistics are similar 
to the population at large, this means that almost all social worker psychotherapists in private 
practice are engaged in some form of split-treatment relationships with prescribing providers. So, 
if there are types of prescribing providers that make better split-treatment partners than others, 
social workers could take this information into account when referring clients from medication 
consultation. This information also might be useful prescribing providers who do not seem as 
helpful, so that their schedules could be readjusted or their professional training could be 
reshaped in order to help them focus on more effective collaborative treatment. 
A third area for further research is how social worker’s preferred treatment techniques 
affect how they perceive psychotropic medications and how they carry out practice in terms of 
talking to clients about medications and communication with prescribing providers. This study 
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did not find any relationships between treatment techniques and these topics, but this does not 
mean that these relationships do not exist. There was only one quantitative question in this study 
that asked participants to list the main treatment techniques that they used. An issue with this is 
that respondents interpreted the meaning of this question in different ways, and were not given 
the specific opportunity to explain how their treatment techniques inform their practice regarding 
psychopharmacological issues. In the future, it might be fruitful to have an open-ended question 
that asks them to discuss this subject. This may develop a better understanding of how 
psychotherapeutic treatment techniques interface with psychopharmacological treatments. 
Based on the information gathered from this study along with previous related research, 
most social workers view psychotropic medications as an important tool in the treatment of 
mental illness. But, it also appears that more work needs to be done to strengthen the working 
relationships between social workers and psychotropic medication providers in order to provide 
all mental health clients and consumers with the best care. It is the responsibility of the social 
work profession to continue to push for research progress that bridges the gap between social 










Adams, K., Matto, H. C., & LeCroy, C. (2009). Limitations of evidence-based practice for social 
work education: Unpacking the complexity. Journal of Social Work Education, 45(2), 
165-186. Retrieved from EBSCOhost. 
Avena, J., & Kalman, T. (2010). Do psychotherapists speak to psychopharmacologists? A survey 
of practicing clinicians. Journal of the American Academy of Psychoanalysis & Dynamic 
Psychiatry, 38(4), 675-683. doi:10.1521/jaap.2010.38.4.675. 
Balon, R. (2001). Positive and negative aspects of split treatment. Psychiatric Annals, 31(10), 
598-603. 
Bentley, Walsh, and Farmer. (2005). Referring clients for medication: Best practices for social 
workers. Best Practices in Mental Health. 1(1), 59-71. 
Bentley, Walsh, and Farmer. (2005). Social work roles and activities regarding psychiatric 
medication: Results of a national survey. Social Work. 50(4). 295-303. 
Bhugra, D., Gupta, S., Smyth, G., & Webber, M. (2010). Through the prism darkly: how do 
others see psychiatrists?. Australasian Psychiatry, 18(1), 7-11. 
doi:10.3109/10398560903274399. 
Davis, M., Barad, M., Otto, M., & Southwick, S. (2006). Combining pharmacotherapy with 
cognitive behavioral therapy: Traditional and new approaches. Journal of Traumatic 
Stress, 19(5), 571-581. doi:10.1002/jts.20149. 
56 
 
Engel, G. L. (1992). The need for a new medical model: A challenge for biomedicine. Family 
Systems Medicine, 10(3), 317-331. doi:10.1037/h0089260. 
Freedman, R. (2009). Matching patients and providers across the United States. Psychiatric 
Services, 60(10), 1293. doi:10.1176/appi.ps.60.10.1323. 
Gutheil, T. G. & Simon, R. I. (2003). Abandonment of patients in split treatment. Harvard 
Review of Psychiatry, 11, 175-179. 
Hansen-Grant, S. & Riba, M. B. (1995). Contact between psychotherapists and psychiatric 
residents who provide medication backup. Psychiatric Services. 46(8), 774-777. 
Kahn, D. A. (1991). Medication consultation and split treatment during psychotherapy. Journal 
of the American Academy of Psychoanalysis, 19(1), 84-98. Retrieved from EBSCOhost. 
King, J. H. & Anderson, S. M. (2004). Therapeutic implications of pharmacotherapy: Current 
trends and ethical issues. Journal of Counseling and Development. 82(3). 329-336. 
Klerman, G.L. (1990). The psychiatric patient’s right to effective treatment: Implications of 
Osheroff v. Chestnut Lodge. American Journal of Psychiatry. 147(4), 409-418. 
Malcom, J. G. (1986). Treatment choices and informed consent in psychiatry; Implications of the 
Osheroff case for the profession. Journal of Psychiatry and Law. 14, 9-107. 
Moses, T. T. (2008). The "Other" effects of psychotropic medication: Social workers' 
perspectives on the psychosocial effects of medication treatment on adolescent clients. 
Child & Adolescent Social Work Journal, 25(3), 205-225. Retrieved from EBSCOhost. 
Moses, T., & Kirk, S. A. (2006). Social workers' attitudes about psychotropic drug treatment 
with youths. Social Work, 51(3), 211-222. Retrieved from EBSCOhost.  
57 
 
Roose, S. P. (2001). Psychodynamic therapy and medication: Can treatments in conflict be 
integrated?. In J. Kay, J. Kay (Eds.), Integrated treatment of psychiatric disorders (pp. 
31-50). Washington, DC US:  American Psychiatric Association.  
Springer, P. R., & Harris, S. M. (2010). Attitudes and beliefs of marriage and family therapists 
regarding psychotropic drugs and therapy. Journal of Marital and Family Therapy, 36(3), 
361-375. Retrieved from EBSCOhost. 
Thomas, K. C., Ellis, A. R., Konrad, T. R., Holzer, C. E., & Morrissey, J. P. (2009). County-
level estimates of mental health professional shortage in the United States. Psychiatric 
Services, 60(10), 1323-1328. doi:10.1176/appi.ps.60.10.1323. 
Walsh, J., Farmer, R., Taylor, M., & Bentley, K. J. (2003). Ethical dilemmas of practicing social 
workers around psychiatric medication: results of a national study. In K. J. Bentley, K. J. 
Bentley (Eds.), Psychiatric medication issues for social workers, counselors, and 




Smith HSR Approval Letter 
 
   
School for Social Work 
  Smith College 
Northampton, Massachusetts 01063 
T (413) 585-7950     F (413) 585-7994 
 
 







You did a very nice job on the revisions. You are approved and ready to go. Thank you very much.  
 
Please note the following requirements: 
 
Consent Forms:  All subjects should be given a copy of the consent form. 
 
Maintaining Data:  You must retain all data and other documents for at least three (3) years past 
completion of the research activity. 
 
In addition, these requirements may also be applicable: 
 
Amendments:  If you wish to change any aspect of the study (such as design, procedures, consent forms 
or subject population), please submit these changes to the Committee. 
 
Renewal:  You are required to apply for renewal of approval every year for as long as the study is active. 
 
Completion:  You are required to notify the Chair of the Human Subjects Review Committee when your 
study is completed (data collection finished).  This requirement is met by completion of the thesis project 
during the Third Summer. 
 




David L. Burton, M.S.W., Ph.D. 
Chair, Human Subjects Review Committee 
 




Informed Consent for Paper Survey 
Dear Participant, 
My name is Rosy Metcalfe and I am a graduate student at Smith College School for Social Work. I am 
conducting a research project to learn more about social workers perspectives on psychotropic medications and 
some of the issues that they encounter regarding this topic in private psychotherapy practice. This study will be 
presented as a thesis and may be used in publications on this topic. 
 
You are being asked to participate in this study if you are able to speak English and are currently a 
Licensed Independent Clinical Social Worker who provides psychotherapy in part-time or full time private practice 
to clients over the age of 18. If you choose to participate, I will ask you to fill out a confidential survey. The survey 
will include some general questions about you and your caseload as well as questions asking you to describe your 
perceptions, beliefs, and experiences regarding psychotropic medications and the prescribing providers of your 
clients’ psychotropic medications, such as psychiatrists and nurse practitioners. I estimate that the amount of time 
you will need to complete this survey will be 20-30 minutes. 
 
Participation in this study may bring up feelings regarding your experiences with psychotropic medications 
as a social worker and your experiences with prescribing providers. Although there will be no financial benefit to 
you for your participation, my hope is that the knowledge and experiences that you share will be beneficial to the 
mental health professions and the clients that we serve. You may also benefit from having the opportunity to share 
your experiences and perspectives, knowing that others will hear about them. 
 
Your confidentiality will be protected in compliance with Federal guidelines. Informed consent forms will 
be removed from surveys and kept in a separate location. Please do not any identifying information in the paper-
based survey.  
 
My Smith thesis research advisor and the Smith data analyst will have access to de-identified data from the 
surveys. In publications or presentations, data will be presented as a whole. Any quotations or case illustrations will 
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be carefully disguised to protect the identity of participants. All data from the surveys will be kept in a secure 
location for a period of three years as per Federal requirements. All data stored electronically will be protected. 
Should I need these materials beyond the three-year period, they will remain secured and will be destroyed once I no 
longer need them. Since this study asks you to discuss your practice as a social worker, I caution you to not identify 
any of your clients. 
 
Participation in this study is voluntary. You may withdraw from this study at any time during the process of 
completing the survey and you have the right to refuse any question. If you have any questions about your rights or 
any aspects of this study, do not hesitate to contact me at  (personal information deleted by Laura H. 
Wyman, 11/30/12) or the Chair of the Smith College School for Social Work Human Rights Subjects Review 
Committee at (413) 585-7974. 
 
BY SIGNING ON THE LINE  BELOW AND WRITING THE DATE, 
YOU INDICATE THAT YOU HAVE READ AND UNDERSTAND THE ABOVE 
INFORMATION; THAT YOU HAVE HAD THE OPPORTUNITY TO ASK 
QUESTIONS ABOUT THE STUDY, YOUR PARTICIPATION, AND YOUR 
RIGHTS; AND THAT YOU AGREE TO PARTICIPATE IN THE STUDY. 
 
Please note: When you mail me the survey using the enclosed self-addressed 
stamped envelope, PLEASE INCLUDE this consent form and keep the second copy 
for your records. PLEASE DO NOT include your return address on the envelope. 
Signature__________________________________________ 
 D a t e _______________ 






Informed Consent for Internet Survey 
Dear Participant, 
My name is Rosy Metcalfe and I am a graduate student at Smith College School for Social Work. I am 
conducting a research project to learn more about social workers perspectives on psychotropic medications and 
some of the issues that they encounter regarding this topic in private psychotherapy practice. This study will be 
presented as a thesis and may be used in publications on this topic. 
 
You are being asked to participate in this study if you are able to speak English and are currently a 
Licensed Independent Clinical Social Worker who provides psychotherapy in part-time or full time private practice 
to clients over the age of 18. If you choose to participate, I will ask you to fill out a anonymous survey. The survey 
will include some general questions about you and your caseload as well as questions asking you to describe your 
perceptions, beliefs, and experiences regarding psychotropic medications and the prescribing providers of your 
clients’ psychotropic medications, such as psychiatrists and nurse practitioners. I estimate that the amount of time 
you will need to complete this survey will be 20-30 minutes. 
 
Participation in this study may bring up feelings regarding your experiences with psychotropic medications 
as a social worker and your experiences with prescribing providers. Although there will be no financial benefit to 
you for your participation, my hope is that the knowledge and experiences that you share will be beneficial to the 
mental health professions and the clients that we serve. You may also benefit from having the opportunity to share 
your experiences and perspectives, knowing that others will hear about them. 
 
Your confidentiality will be protected in compliance with Federal guidelines.  Your IP address will remain 
anonymous though the use of SurveyMonkey.Please do not include your name or any other identifying information 
in the internet survey.  
 
My Smith thesis research advisor and the Smith data analyst will have access to de-identified data from the 
surveys. In publications or presentations, data will be presented as a whole. Any quotations or case illustrations will 
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be carefully disguised to protect the identity of participants. All data from the surveys will be kept in a secure 
location for a period of three years as per Federal requirements. All data sored electronically will be protected. 
Should I need these materials beyond the three-year period, they will remain secured and will be destroyed once I no 
longer need them. Since this study asks you to discuss your practice as a social worker, I caution you to not identify 
any of your clients. 
 
Participation in this study is voluntary. You may withdraw from this study at any time during the process of 
completing the survey and you have the right to refuse any question. You may withdraw from this study by logging 
off of the internet survey or destroying the paper-based survey.  Once you have clicked “submit” on the internet 
survey or mailed your paper-based survey, I will not be able to remove your survey because I will not be able to 
identify your survey from the other surveys in my study. 
If you have any questions about your rights or any aspects of this study, do not hesitate to contact me at  (personal 
information deleted by Laura H. Wyman, 11/30/12) or the Chair of the Smith College School for Social 
Work Human Rights Subjects Review Committee at (413) 585-7974. 
 
BY CHECKING "YES" THE BOX BELOW, YOU INDICATE THAT YOU HAVE READ AND UNDERSTAND 
THE ABOVE INFORMATION; THAT YOU HAVE HAD THE OPPORTUNITY TO ASK QUESTIONS ABOUT 
THE STUDY, YOUR PARTICIPATION, AND YOUR RIGHTS; AND THAT YOU AGREE TO PARTICIPATE 
IN THE STUDY. PLEASE PRINT A COPY OF THIS PAGE FOR YOUR RECORDS. 
 
I AGREE TO PARTICIPATE 
[  ] YES 













1) Are you currently a Licensed Independent Clinical Social Worker (LICSW)? [Yes/No] 
 
2) Do you perform psychotherapy in private practice? [Yes/No] 
 
3) Do you work with individual clients over the age of 18? [Yes/No] 
 
*If you answered “Yes” to all three of these questions, please go on to the informed consent on the next page. 
 
**If you answered “No” to any one of these questions, you are not eligible to participate in this study. Thank you for 
your time and interest. 
 
 
Note: When answering the questions on this survey, these questions are specific to your work with private practice 


















Black or African American 
Hispanic or Latino 
Multiracial 
Native Hawaiian or other Pacific Islander 
White 
Other (please specify): 
 





5) Treatment Techniques you use (select all that apply)  
Coaching 
Cognitive Behavioral (CBT) 




Mindfulness Based Cognitive Therapy (MBCT) 
Psychoanalytic 
Psychodynamic 
Other (please specify) 
 





7) Total Caseload of Individual Therapy Clients in your private practice 
________ 
 















Other (please Specify) 
 
9) Percent of your adult individual caseload who are currently taking psychotropic medications 







Section A: Working with Providers of Psychotropic Medications 
 
1) Types of prescribing practitioners who your clients use for their psychotropic medications. Specify how many of 
each type of clinician you communicate with and frequently you had contact with each type of practitioner in the last 
six months. 
 
 Psychiatrists __ 
More than once a week 
Once a week 
Once a month 
Less than once a month 
65 
 
Not at all 
 
Primary Care Doctors__ 
More than once a week 
Once a week 
Once a month 
Less than once a month 
Not at all 
 
Psychiatric Nurse Practitioners and Psychiatric Physician’s Assistants__ 
More than once a week 
Once a week 
Once a month 
Less than once a month 
Not at all 
 
Primary Care Nurses and Physician’s Assistants__ 
More than once a week 
Once a week 
Once a month 
Less than once a month 
Not at all 
 
 
2) With clients that are currently taking psychotropic medications for mild to moderate forms of mental illness, how 
frequently to you communicate with these clients’ prescribing practitioner on average? (Examples include Mild to 
moderate anxiety and/or depression, adjustment disorders, etc.) 
More than once a week 
Once a week 
Once a month 
Once every three months 
Once a year 
Less than once a year 
 
3) With clients that are currently taking psychotropic medications for more serious forms of mental illness, how 
frequently do you communicate with these clients’ prescribing providers? (Examples include Bipolar Affective 
Disorder, Psychosis, Major Depression, etc.) 
More than once a week 
Once a week 
Once a month 
Once every three months 
Once a year 
Less than once a year 
 
4) Regarding the issue of psychotropic medications, I find psychotropic medication providers to be helpful and 
supportive to my clients.  
A) Psychiatrists  
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
B) Primary Care Doctors  
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
C) Psychiatric Nurse Practitioners and Psychiatric Physician’s Assistants 
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
D) Primary Care Nurses and Physician’s Assistants 




5) Describe the issue that you encounter most frequently when communicating with your clients prescribers of 
psychotropic medications. 
 
6) Is there anything you would like to add? 
 
Section B: Your perspectives on psychotropic medications 
 
 
1) Psychotropic medications are helpful for my clients who struggle with…  
 
A) Mild to Moderate Anxiety 
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
B) Severe Anxiety 
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
C) Mild to Moderate Depression 
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
D) Severe Depression 
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
 E) Mood Instability 
 Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
 F) Psychotic Symptoms 
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure 
 
2) What issue do your clients struggle with most with regarding psychotropic medications? Please describe. 
 
3) What dilemma do you face the most when discussing psychotropic medications with your clients? Please 
describe. 
 















Dear ___________ , 
I am writing to ask for your participation in my study on how social workers in private practice view the role of 
psychotropic medications in treatment and handle psychopharmacological issues in practice. In my study, I am 
hoping to collect information from a diverse sample of Licensed Independent Clinical Social Workers in either part-
time or full-time private practice to gather a better understanding of how social workers in private practice perceive 
psychotropic medications, how they handle issues regarding medication with their clients and how the communicate 
with prescribing practitioners. Participants must be able to speak English, be currently licensed independent clinical 
social workers and be providing psychotherapy in private practice to adult clients.  
For the study, participants will be asked to fill out a confidential survey. If you are interested, you can access the 
survey anonymously at https://www.surveymonkey.com/s/6X8MY6K if you have an internet connection or you can 
call me at  (personal information deleted by Laura H. Wyman, 11/30/12) for a printed version which I will 
mail to with a self-addressed/stamped envelope. If you call me for the printed version, you will not have to give their 
name, only your mailing address. In addition, please forward this email or my phone number along to any of your 
own contacts who might be interested in participating in the study or aiding me in the recruitment process. Thank 
you very much for your support. If you are interested in hearing about my findings when I have completed my 
study, please contact me. Also, if you have any questions, do not hesitate to get in touch with me. 
Sincerely, 
 




Recruitment Telephone Greeting 
My name is Rosy Metcalfe. I am currently a master’s degree student at Smith College School for Social 
Work. I am contacting to ask for your participation in my study on how social workers in private practice view the 
role of psychotropic medications in treatment and handle psychopharmacological issues in practice. In my study, I 
am hoping to collect information from a diverse sample of Licensed Independent Clinical Social Workers in part-
time or full-time private practice to gather a better understanding of how you perceive psychotropic medications, 
how you handle issues regarding medication with their clients and how you communicate with prescribing 
practitioners. Participants must be currently licensed independent clinical social workers and be providing 
psychotherapy in private practice to adult clients. For the study, you will be asked to fill out a confidential survey. If 
you are interested, I can email you the link to my survey website, or I you prefer I not to be emailed, the address for 
my anonymous survey is https://www.surveymonkey.com/s/6X8MY6K.  
I can also mail you a printed version, which I will mail to with a self-addressed/stamped envelope. If you 
call me for the printed version, you will not have to give their name, only your mailing address. In addition, please 
forward this survey website or my phone number along to any of your own contacts who might be interested in 
participating in the study or aiding me in the recruitment process.  
Thank you very much for your support. If you are interested in hearing about my findings when I have 
completed my study, please contact me. Also, if you have any questions, do not hesitate to get in touch with me. 
Thank for your time. 
 
 
